Management of Packaging Artwork Design for Medicines in the Pharmaceutical Industry: Standardised Labeling and Package Leaflet Requirements and their Assessment Process in the European Centralised Procedure

Artwork design involves creating and developing visual components, layouts, and graphic illustrations used in the packaging and labeling of medicinal products. These designs represent a paramount role in linking essential information about medications and ensuring adherence to regulatory compliance. Despite their significance, pharmaceutical industries confront several hindrances in artwork design, such as meeting regulatory requirements, maintaining brand consistency, addressing multilingual needs, and managing time and cost constraints.

This article discusses the process of managing packaging artwork design within the pharmaceutical industry and outlines the EU regulatory requirements aimed at standardizing artwork compliance. It elucidates the assessment process according to the Directives and Regulations for mock-ups and specimens of immediate (primary) and outer (secondary) labeling, as well as package leaflets for medicinal products in the centralized procedure.

The article also outlines a comparison of labeling workflows and submission processes across the EU, US, Australia, and Japan. Furthermore, it highlights the influence of packaging artwork on brand recognition and marketing approach, emphasizing patient safety through precise pharmaceutical packaging information. Additionally, it expounds the significance of artwork review and change control management. It also shows the proportion of recalls in the US and the EU over the past years. It outlines strategic perspectives and the latest updates that are influencing EU labeling practices in 2025.